Price target
2,151.20DINR+633.20+41.71%
The 14 analysts offering 1 year price forecasts for J.B.CHEMICALS & PHARMACEUTICAL have a max estimate of 2,446.00 and a min estimate of 1,784.00.
Analyst rating
Based on 14 analysts giving stock ratings to J.B.CHEMICALS & PHARMACEUTICAL in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
12
Buy
1
Hold
0
Sell
1
Strong sell
0
EPS
Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
3.00
6.00
9.00
12.00
Reported
Estimate
Currency: INR
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Reported
9.20
9.70
8.60
8.10
11.35
11.20
10.40
—
Estimate
7.21
11.87
9.12
7.34
10.08
11.04
10.20
6.70
Surprise
+27.65%
−18.27%
−5.70%
+10.35%
+12.60%
+1.45%
+1.96%
—
Revenue
Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
3.00 B
6.00 B
9.00 B
12.00 B
Reported
Estimate
Currency: INR
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Reported
8.96 B
8.82 B
8.45 B
8.62 B
10.04 B
10.01 B
9.63 B
—
Estimate
8.79 B
9.00 B
8.67 B
8.51 B
10.07 B
10.01 B
9.82 B
10.34 B
Surprise
+1.99%
−2.04%
−2.56%
+1.27%
−0.26%
−0.02%
−1.87%
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
JBCHEPHARM EPS for the last quarter is 10.40 INR despite the estimation of 10.20 INR. In the next quarter EPS is expected to reach 6.70 INR. Track more of J.B.CHEMICALS & PHARMACEUTICAL financials and stay on top of what is up with the company.
In the next quarter J.B.CHEMICALS & PHARMACEUTICAL revenue is expected to reach 10.34 B INR. Check out J.B.CHEMICALS & PHARMACEUTICAL revenue and earnings and make informed decisions.
According to analysts, JBCHEPHARM price target is 2,151.21 INR with a max estimate of 2,446.00 INR and a min estimate of 1,784.00 INR. Check if this forecast comes true in a year, meanwhile watch J.B.CHEMICALS & PHARMACEUTICAL stock price chart and keep track of the current situation with JBCHEPHARM news and stock market news.
We've gathered opinions of 14 analysts rating JBCHEPHARM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.